Literature DB >> 25703422

Transient carotid ischemia as a remote conditioning stimulus for myocardial protection in anesthetized rabbits: Insights into intracellular signaling.

Ioanna Andreadou1, Sofia-Iris Bibli2, Emmanuel Mastromanolis3, Anastasia Zoga3, Panagiotis Efentakis2, Nikolaos Papaioannou4, Dimitrios Farmakis3, Dimitrios Th Kremastinos3, Efstathios K Iliodromitis3.   

Abstract

BACKGROUND: We investigated the effectiveness of perconditioning (Perc) applied at different time points along with the role of RISK, SAFE, STAT5 and eNOS pathways. METHODS AND
RESULTS: Anesthetized rabbits were subjected to 30-min ischemia/3-hour reperfusion. Perc, consisted of 4 cycles of 1-min ischemia/reperfusion, was applied in the carotid artery at different time points. Perc was started and ended during ischemia, started during ischemia and ended at the beginning of reperfusion, started at the end of ischemia and ended at reperfusion and started and ended during reperfusion. The PI3K inhibitor wortmannin, or the JAK-2 inhibitor AG490, was also applied and the infarct size was assessed. In another series assigned to the previous groups, the phosphorylation of Akt, PI3K, ERKs1/2, GSK3β, STAT3, and STAT5 was evaluated. All Perc groups had smaller infarction compared to those without Perc, independently of PI3K or JAK-2 inhibition. STAT5 was the only molecule that was phosphorylated in parallel with cardioprotection. Since Src and angiotensin II mediate the STAT5 pathway, we administered the Scr inhibitor PP1 and the angiotensin II receptor antagonist valsartan. PP1 and valsartan prevented STAT5 phosphorylation, but did not abrogate the effect of Perc. Furthermore, the NOS inhibitor L-NAME was administered and abrogated the infarct size limiting effect of Perc. In parallel, the expression of cleaved caspase-3 was elevated only in the control and Perc-A-L-NAME groups.
CONCLUSION: Perc reduces infarction independently of RISK, SAFE and STAT5 pathways. Src kinase and angiotensin II play a predominant role in STAT5 activation. eNOS may protect the myocardium through inhibition of apoptosis.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cardioprotection; Perconditioning; RISK; SAFE; STAT5; eNOS

Mesh:

Year:  2015        PMID: 25703422     DOI: 10.1016/j.ijcard.2015.01.079

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  7 in total

Review 1.  Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection.

Authors:  Hans Erik Bøtker; Derek Hausenloy; Ioanna Andreadou; Salvatore Antonucci; Kerstin Boengler; Sean M Davidson; Soni Deshwal; Yvan Devaux; Fabio Di Lisa; Moises Di Sante; Panagiotis Efentakis; Saveria Femminò; David García-Dorado; Zoltán Giricz; Borja Ibanez; Efstathios Iliodromitis; Nina Kaludercic; Petra Kleinbongard; Markus Neuhäuser; Michel Ovize; Pasquale Pagliaro; Michael Rahbek-Schmidt; Marisol Ruiz-Meana; Klaus-Dieter Schlüter; Rainer Schulz; Andreas Skyschally; Catherine Wilder; Derek M Yellon; Peter Ferdinandy; Gerd Heusch
Journal:  Basic Res Cardiol       Date:  2018-08-17       Impact factor: 17.165

2.  Remote ischemic perconditioning prevents liver transplantation-induced ischemia/reperfusion injury in rats: Role of ROS/RNS and eNOS.

Authors:  Ning He; Jun-Jun Jia; Jian-Hui Li; Yan-Fei Zhou; Bing-Yi Lin; Yi-Fan Peng; Jun-Jie Chen; Tian-Chi Chen; Rong-Liang Tong; Li Jiang; Hai-Yang Xie; Lin Zhou; Shu-Sen Zheng
Journal:  World J Gastroenterol       Date:  2017-02-07       Impact factor: 5.742

3.  Empagliflozin Limits Myocardial Infarction in Vivo and Cell Death in Vitro: Role of STAT3, Mitochondria, and Redox Aspects.

Authors:  Ioanna Andreadou; Panagiotis Efentakis; Evangelos Balafas; Gabriele Togliatto; Constantinos H Davos; Aimilia Varela; Constantinos A Dimitriou; Panagiota-Efstathia Nikolaou; Eirini Maratou; Vaia Lambadiari; Ignatios Ikonomidis; Nikolaos Kostomitsopoulos; Maria F Brizzi; George Dimitriadis; Efstathios K Iliodromitis
Journal:  Front Physiol       Date:  2017-12-19       Impact factor: 4.566

4.  Impact of Administration Time and Kv7 Subchannels on the Cardioprotective Efficacy of Kv7 Channel Inhibition.

Authors:  Jan Hansen; Jacob Johnsen; Jan Møller Nielsen; Charlotte Brandt Sørensen; Casper Carlsen Elkjær; Nichlas Riise Jespersen; Hans Erik Bøtker
Journal:  Drug Des Devel Ther       Date:  2020-07-02       Impact factor: 4.162

Review 5.  Cardioprotection in right heart failure.

Authors:  Kerstin Boengler; Klaus-Dieter Schlüter; Ralph Theo Schermuly; Rainer Schulz
Journal:  Br J Pharmacol       Date:  2020-03-09       Impact factor: 8.739

6.  Impact of Maturation on Myocardial Response to Ischemia and the Effectiveness of Remote Preconditioning in Male Rats.

Authors:  Lucia Kindernay; Veronika Farkasova; Jan Neckar; Jaroslav Hrdlicka; Kirsti Ytrehus; Tanya Ravingerova
Journal:  Int J Mol Sci       Date:  2021-10-12       Impact factor: 5.923

7.  Remote Ischemic Perconditioning Ameliorates Myocardial Ischemia and Reperfusion-Induced Coronary Endothelial Dysfunction and Aortic Stiffness in Rats.

Authors:  Petra Lujza Szabó; Christopher Dostal; Patrick Michael Pilz; Ouafa Hamza; Eylem Acar; Simon Watzinger; Shalett Mathew; Gerd Kager; Seth Hallström; Bruno K Podesser; Attila Kiss
Journal:  J Cardiovasc Pharmacol Ther       Date:  2021-08-03       Impact factor: 2.457

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.